Kids flu cases predicted to spike if vaccine rates remain low GPs have been urged to promote the vaccine among patients with young children, with just 28% of kids receiving the lifesaving immunisation.
Why the emergence of JN.1 is significant The new COVID variant is an evolutionary ‘step change’ in the pandemic, according to Australian researchers.
How long does immunity last after a COVID infection? Dr Lara Herrero and Wesley Freppel assess the latest evidence, including the impact vaccination and emerging variants can have.
Real-world evidence demonstrates efficacy of HPV vaccine Zero cases of cervical cancer have been detected in Scotland among those who received the bivalent vaccine by age 12.
Study links blood protein changes to long COVID Researchers are hopeful that the findings could help improve diagnosis and treatment of a condition it says remains ‘poorly understood’.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
New COVID variant ‘taking off like a rocket’ Despite states and territories reporting large case increases, many Australians have not received booster vaccinations to protect against JN.1.
Tighten Paxlovid eligibility: PBAC advice The committee that looks at PBS listings has recommended the first-line COVID-19 treatment be limited to the highest risk patients aged 50–69 years.
Primary care boost key to better pandemic response: Report The Grattan Institute has set out why it believes improved funding would reduce the higher toll on the most vulnerable communities.
GPs crucial to fighting future pandemics: RACGP The college is calling for recognition of GPs as frontline workers if a pandemic hits, while pleading with leaders to ‘cut us some slack’.